MMSI Stock - Merit Medical Systems, Inc.
Unlock GoAI Insights for MMSI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.36B | $1.26B | $1.15B | $1.07B | $963.88M |
| Gross Profit | $643.33M | $583.87M | $519.10M | $485.33M | $401.18M |
| Gross Margin | 47.4% | 46.4% | 45.1% | 45.2% | 41.6% |
| Operating Income | $155.69M | $123.94M | $87.56M | $60.92M | $-1,562,000 |
| Net Income | $120.36M | $94.41M | $74.52M | $48.45M | $-9,843,000 |
| Net Margin | 8.9% | 7.5% | 6.5% | 4.5% | -1.0% |
| EPS | $2.07 | $1.64 | $1.31 | $0.86 | $-0.18 |
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| March 28th 2025 | JP Morgan | Initiation | Overweight | $120 |
| December 11th 2024 | Wells Fargo | Upgrade | Overweight | $120← $103 |
| June 28th 2024 | Robert W. Baird | Initiation | Outperform | $96 |
| April 11th 2024 | CL King | Initiation | Buy | $88 |
| February 7th 2024 | BofA Securities | Initiation | Neutral | $87 |
| December 21st 2023 | Canaccord Genuity | Upgrade | Buy | $100 |
| December 20th 2022 | Canaccord Genuity | Downgrade | Hold | $72← $73 |
Earnings History & Surprises
MMSIEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 22, 2026 | — | — | — | — |
Q1 2026 | Feb 24, 2026 | $0.95 | — | — | — |
Q4 2025 | Oct 30, 2025 | $0.82 | $0.92 | +12.2% | ✓ BEAT |
Q3 2025 | Jul 30, 2025 | $0.86 | $1.01 | +17.4% | ✓ BEAT |
Q2 2025 | Apr 24, 2025 | $0.75 | $0.86 | +14.8% | ✓ BEAT |
Q1 2025 | Feb 25, 2025 | $0.82 | $0.93 | +13.4% | ✓ BEAT |
Q4 2024 | Oct 30, 2024 | $0.80 | $0.86 | +7.5% | ✓ BEAT |
Q3 2024 | Aug 1, 2024 | $0.88 | $0.92 | +4.5% | ✓ BEAT |
Q2 2024 | Apr 30, 2024 | $0.71 | $0.77 | +8.5% | ✓ BEAT |
Q1 2024 | Feb 28, 2024 | $0.77 | $0.81 | +5.2% | ✓ BEAT |
Q4 2023 | Oct 26, 2023 | $0.65 | $0.75 | +15.4% | ✓ BEAT |
Q3 2023 | Jul 25, 2023 | $0.75 | $0.81 | +8.0% | ✓ BEAT |
Q2 2023 | Apr 26, 2023 | $0.55 | $0.64 | +16.4% | ✓ BEAT |
Q1 2023 | Feb 22, 2023 | $0.67 | $0.79 | +17.9% | ✓ BEAT |
Q4 2022 | Oct 26, 2022 | $0.53 | $0.64 | +20.8% | ✓ BEAT |
Q3 2022 | Jul 27, 2022 | $0.58 | $0.73 | +25.9% | ✓ BEAT |
Q2 2022 | Apr 27, 2022 | $0.47 | $0.53 | +12.8% | ✓ BEAT |
Q1 2022 | Feb 24, 2022 | $0.50 | $0.71 | +42.0% | ✓ BEAT |
Q4 2021 | Oct 28, 2021 | $0.44 | $0.52 | +18.2% | ✓ BEAT |
Q3 2021 | Jul 29, 2021 | $0.44 | $0.62 | +40.9% | ✓ BEAT |
Latest News
Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $99
📈 PositiveBarrington Research Maintains Outperform on Merit Medical Systems, Maintains $106 Price Target
📈 PositiveCanaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $93
➖ NeutralWells Fargo Maintains Overweight on Merit Medical Systems, Lowers Price Target to $95
📈 PositiveMerit Medical Systems Presents 24-Month Efficacy Findings From Non-Randomized AVG Cohort Of WAVE Trial At VEINS Conference
➖ NeutralBarrington Research Maintains Outperform on Merit Medical Systems, Raises Price Target to $106
📈 PositivePiper Sandler Reiterates Overweight on Merit Medical Systems, Raises Price Target to $109
📈 PositiveMerit Medical Systems shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 guidance above estimates.
📈 PositiveNeedham Reiterates Buy on Merit Medical Systems, Maintains $108 Price Target
📈 PositiveMerit Medical Systems shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 guidance above estimates.
📈 PositiveMerit Medical Systems Raises FY2025 Adj EPS Guidance from $3.52-$3.72 to $3.66-$3.79 vs $3.63 Est; Raises FY2025 Sales Guidance from $1.495B-$1.507B to $1.502B-$1.515B vs $1.500B Est
📈 PositiveMerit Medical Systems Q3 Adj. EPS $0.92 Beats $0.83 Estimate, Sales $384.157M Beat $371.912M Estimate
📈 PositiveCanaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $104
📈 PositiveMerit Medical Systems Says Acquisition Projected To Dilutive To Merit's 2025 GAAP Eps By $0.01 And Non-GAAP EPS By $0.01; Projected To Contribute Revenue In The Range Of ~$6M To $8M For The 12-Months Ending December 31, 2026
➖ NeutralMerit Medical Systems Signs A Definitive Asset Purchase Agreement With Pentax Of America, A Subsidiary Of PENTAX Medical, To Acquire The C2 CryoBalloon Device And Related Technology For Total Purchase Consideration Of $22M
📈 PositiveBarrington Research Maintains Outperform on Merit Medical Systems, Maintains $103 Price Target
📈 PositiveMerit Medical's SCOUT Radar Localization Reaches 750,000 Patients Worldwide
📈 PositiveMerit Medical's Embosphere Microspheres Approved In EU For Knee Osteoarthritis Treatment
📈 PositiveMerit Medical Systems Announces Enrollment Of First Patient In WRAP North America Registry
📈 PositiveMerit Medical names Martha Aronson as President and CEO
➖ NeutralFrequently Asked Questions about MMSI
What is MMSI's current stock price?
What is the analyst price target for MMSI?
What sector is Merit Medical Systems, Inc. in?
What is MMSI's market cap?
Does MMSI pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to MMSI for comparison